IRIS UniCatt

Leone, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.691
EU - Europa 12.250
AS - Asia 8.691
SA - Sud America 1.422
Continente sconosciuto - Info sul continente non disponibili 242
AF - Africa 234
OC - Oceania 191
Totale 38.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.272
DE - Germania 5.178
SG - Singapore 3.551
CN - Cina 2.791
SE - Svezia 1.586
BR - Brasile 1.144
IT - Italia 1.077
UA - Ucraina 1.077
FR - Francia 809
GB - Regno Unito 642
VN - Vietnam 638
PL - Polonia 498
IE - Irlanda 389
IN - India 351
FI - Finlandia 269
ID - Indonesia 249
CA - Canada 214
TR - Turchia 198
JP - Giappone 191
RU - Federazione Russa 189
AU - Australia 163
BD - Bangladesh 141
HK - Hong Kong 121
NL - Olanda 108
AR - Argentina 106
MX - Messico 106
IQ - Iraq 78
ES - Italia 70
ZA - Sudafrica 57
BE - Belgio 50
CI - Costa d'Avorio 49
EC - Ecuador 36
IR - Iran 36
PK - Pakistan 36
VE - Venezuela 36
CO - Colombia 34
SA - Arabia Saudita 34
CH - Svizzera 32
AT - Austria 30
NO - Norvegia 28
RO - Romania 28
EG - Egitto 27
NZ - Nuova Zelanda 27
KR - Corea 25
UZ - Uzbekistan 25
IL - Israele 24
JO - Giordania 23
MA - Marocco 22
AE - Emirati Arabi Uniti 21
CL - Cile 21
PH - Filippine 20
BG - Bulgaria 19
LT - Lituania 19
PY - Paraguay 19
KE - Kenya 18
CZ - Repubblica Ceca 17
GR - Grecia 17
CR - Costa Rica 16
HU - Ungheria 16
JM - Giamaica 16
MY - Malesia 16
DZ - Algeria 15
PT - Portogallo 15
AZ - Azerbaigian 13
HN - Honduras 13
TH - Thailandia 13
SK - Slovacchia (Repubblica Slovacca) 12
NP - Nepal 11
UY - Uruguay 11
DO - Repubblica Dominicana 10
ET - Etiopia 10
KZ - Kazakistan 10
OM - Oman 10
HR - Croazia 9
LB - Libano 9
LV - Lettonia 9
TN - Tunisia 9
GE - Georgia 8
PE - Perù 8
RS - Serbia 8
AL - Albania 7
BO - Bolivia 7
EU - Europa 7
AM - Armenia 6
BB - Barbados 6
DK - Danimarca 6
LU - Lussemburgo 6
PR - Porto Rico 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
BZ - Belize 5
LK - Sri Lanka 5
MK - Macedonia 5
NI - Nicaragua 5
PS - Palestinian Territory 5
GH - Ghana 4
KG - Kirghizistan 4
Totale 38.415
Salva come PNG Salva come JPEG
Città #
Singapore 1.923
Ashburn 1.606
Chandler 1.583
San Jose 1.066
Jacksonville 688
Beijing 502
Nanjing 449
San Mateo 445
Warsaw 445
Dearborn 440
Dublin 375
Ann Arbor 345
Nürnberg 328
Los Angeles 310
Houston 302
Woodbridge 279
New York 278
Wilmington 257
Milan 231
Jakarta 217
Seattle 206
Munich 205
Hangzhou 187
Lauterbourg 187
Ho Chi Minh City 184
Hefei 180
Hanoi 177
Nanchang 177
Tokyo 154
Redwood City 152
Boston 148
Lawrence 147
Dallas 139
Izmir 135
Fairfield 134
Bremen 129
Frankfurt am Main 127
Buffalo 124
Marseille 120
Moscow 112
Chicago 110
Hong Kong 104
Rome 103
São Paulo 101
Lancaster 100
Kunming 99
Santa Clara 95
Cattolica 84
Orem 80
Shenyang 78
Atlanta 76
Guangzhou 73
Zhengzhou 72
University Park 67
Tianjin 66
Hebei 61
San Francisco 59
Leawood 58
Princeton 58
London 57
The Dalles 57
Mountain View 55
Boardman 54
Brooklyn 52
Shanghai 52
Redmond 51
Council Bluffs 50
Abidjan 49
Changsha 49
Jiaxing 48
Toronto 47
Auburn Hills 45
Norwalk 45
Brussels 44
Cambridge 44
Philadelphia 44
Phoenix 44
Helsinki 43
Denver 42
Kent 40
Pune 39
Da Nang 38
Sydney 38
Memphis 36
Jinan 35
Amsterdam 34
Fremont 34
Paris 32
Augusta 31
Baghdad 31
Chennai 31
Detroit 31
Düsseldorf 31
Portland 31
Rio de Janeiro 31
Melbourne 30
Montreal 30
Haiphong 29
Johannesburg 28
San Diego 28
Totale 18.397
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.866
Factors associated with mortality in bacteremic patients with haematologic malignancies 529
Incidence of acute myeloid leukemia after breast cancer 386
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 366
Fanconi anemia gene variants in therapy-related myeloid neoplasms 331
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 305
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 299
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 292
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 289
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 284
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 283
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 272
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 266
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 253
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 247
G20210A protrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 245
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 245
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 244
A) A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 243
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 240
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 239
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 237
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 237
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 236
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 233
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 231
Correlation between paraproteinaemia and viral reactivation after allo-SCT 229
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 229
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 224
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 224
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 221
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 217
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 215
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype 213
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 211
Von hippel-lindau disease and erythrocytosis 211
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 209
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 208
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 208
Why methylation is not a marker predictive of response to hypomethylating agents 204
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 203
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 202
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 202
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 200
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 200
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 198
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 195
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 194
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 194
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 194
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 194
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 194
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 191
Iron in Hodgkin's lymphoma 189
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 188
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 188
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 188
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 187
Epigenetic changes in therapy-related MDS/AML 187
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 187
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 187
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 187
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 186
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 184
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 184
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 184
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 181
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 181
Non-invasive detection of fetal Rhesus D Status: A comparison between Polymerase Chain Reaction and flow Cytometry 179
T lymphocyte subsets and platelet-associated IgG in idiopathic thrombocytopenic purpura: effect of splenectomy. 179
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 178
Clonal evolution in therapy-related neoplasms 178
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 177
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 177
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 177
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 177
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 175
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 174
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 174
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 174
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 173
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation 173
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 172
Similarities and differences between therapy-related and elderly acute myeloid leukemia 172
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 172
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 171
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 171
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 171
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 171
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 171
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 169
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 168
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 168
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 167
Primary plasma cell leukemia followed by testicular plasmacytoma 166
Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia [9] 165
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 165
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 163
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 163
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 163
Totale 24.763
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.856 0 242 35 105 138 77 54 342 86 137 281 359
2022/20234.307 512 631 328 716 302 523 220 342 503 46 118 66
2023/20242.537 102 566 88 109 148 383 122 104 99 179 354 283
2024/20254.293 322 246 394 177 437 120 147 208 668 336 658 580
2025/202610.193 1.446 327 546 869 1.654 610 1.814 599 796 682 400 450
2026/20271.437 453 984 0 0 0 0 0 0 0 0 0 0
Totale 38.721